95 related articles for article (PubMed ID: 2978935)
21. [Changes in the thresholds of the behavioral escape reaction in the administration of a beta-endorphin antiserum to rats].
Litvinova SV; Aristova VV; Aristov IuA; Kaliuzhnyĭ LV; Shul'govskiĭ VV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(2):370-2. PubMed ID: 2526421
[No Abstract] [Full Text] [Related]
22. EEG spectral power and mean frequencies in early heroin abstinence.
Polunina AG; Davydov DM
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):73-82. PubMed ID: 14687860
[TBL] [Abstract][Full Text] [Related]
23. Alterations of immune functions in heroin addicts and heroin withdrawal subjects.
Govitrapong P; Suttitum T; Kotchabhakdi N; Uneklabh T
J Pharmacol Exp Ther; 1998 Aug; 286(2):883-9. PubMed ID: 9694946
[TBL] [Abstract][Full Text] [Related]
24. [Neonatal findings in children of drug-addicted mothers].
Echevarría J; Callen M; Alustiza E; Orueta Y; Traba L; Paisán L
An Esp Pediatr; 1983 Dec; 19(6):439-43. PubMed ID: 6666886
[TBL] [Abstract][Full Text] [Related]
25. [Beta-carbolines (harman/norharman) are increased in heroin dependent patients].
Stohler R; Rommelspacher H; Ladewig D; Dammann G
Ther Umsch; 1993 Mar; 50(3):178-81. PubMed ID: 8475471
[TBL] [Abstract][Full Text] [Related]
26. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?
Kiefer F; Horntrich M; Jahn H; Wiedemann K
Psychopharmacology (Berl); 2002 Aug; 162(4):433-7. PubMed ID: 12172698
[TBL] [Abstract][Full Text] [Related]
27. Heroin addicts have increased platelet alpha 2-adrenoceptor densities which correlate with the severity of the abstinence syndrome.
Garcia-Sevilla JA; Ugedo L; Ulibarri I; Elizagarate E; Gutierrez M
Eur J Pharmacol; 1984 Apr; 100(1):131-2. PubMed ID: 6327323
[No Abstract] [Full Text] [Related]
28. [Use of transcranial electrical stimulation for managing the alcohol abstinence syndrome].
Grinenko AIa; Krupitskiĭ EM; Lebedev VP; Katsnel'son IaS; Karandashova GF
Fiziol Cheloveka; 1988; 14(2):212-8. PubMed ID: 2970412
[No Abstract] [Full Text] [Related]
29. Long-term abstinence syndrome in heroin addicts: indices of P300 alterations associated with a short memory task.
Papageorgiou CC; Liappas IA; Ventouras EM; Nikolaou CC; Kitsonas EN; Uzunoglu NK; Rabavilas AD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1109-15. PubMed ID: 15610923
[TBL] [Abstract][Full Text] [Related]
30. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
31. Integration of Molecular Inflammatory Interactome Analyses Reveals Dynamics of Circulating Cytokines and Extracellular Vesicle Long Non-Coding RNAs and mRNAs in Heroin Addicts During Acute and Protracted Withdrawal.
Zhang Z; Wu H; Peng Q; Xie Z; Chen F; Ma Y; Zhang Y; Zhou Y; Yang J; Chen C; Li S; Zhang Y; Tian W; Wang Y; Xu Y; Luo H; Zhu M; Kuang YQ; Yu J; Wang K
Front Immunol; 2021; 12():730300. PubMed ID: 34489980
[TBL] [Abstract][Full Text] [Related]
32. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
Shi J; Jun W; Zhao LY; Xue YX; Zhang XY; Kosten TR; Lu L
Eur J Pharmacol; 2009 Aug; 615(1-3):108-12. PubMed ID: 19470385
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic changes in acute opiate withdrawal.
Stuart Reece A
QJM; 2009 May; 102(5):357. PubMed ID: 19028746
[No Abstract] [Full Text] [Related]
34. [A biological marker in drug dependence: microcirculatory homeostasis].
Marconi G; Labate M; Catalucci F; Sergio G; Ribezzo MG; Proietti MG
Minerva Med; 1986 Aug; 77(32-33):1481-3. PubMed ID: 3736986
[TBL] [Abstract][Full Text] [Related]
35. Alpha-1- and 2-adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression.
Gerra G; Caccavari R; Marcato A; Zaimovic A; Avanzini P; Monica C; Mutti A; Fontanesi B; Delsignore R; Brambilla F
Acta Psychiatr Scand; 1994 Oct; 90(4):269-73. PubMed ID: 7831997
[TBL] [Abstract][Full Text] [Related]
36. Severity of Withdrawal Symptoms, Plasma Oxytocin Levels, and Treatment Outcome in Heroin Users Undergoing Acute Withdrawal.
Nikolaou K; Kapoukranidou D; Ndungu S; Floros G; Kovatsi L
J Psychoactive Drugs; 2017; 49(3):233-241. PubMed ID: 28443705
[TBL] [Abstract][Full Text] [Related]
37. [Guidelines and criteria concerning the admission of heroin addicts to the general hospital].
Camí Morell J; de Torres Sanahuja S; San Molina L
Med Clin (Barc); 1984 Feb; 82(7):327-31. PubMed ID: 6371401
[No Abstract] [Full Text] [Related]
38. Alcoholism, anxiety, and opioid-dopaminergic interactions.
Sher L
Psychopharmacology (Berl); 2003 Jan; 165(2):202-3. PubMed ID: 12428151
[No Abstract] [Full Text] [Related]
39. [Comparative evaluation of clinical symptoms and status of bone metabolism in patients with heroin and buprenorphine addiction in the period of withdrawal].
Sikharulidze ZD; Kopaliani MG; Kilasoniia LO
Georgian Med News; 2006 May; (134):72-6. PubMed ID: 16783071
[TBL] [Abstract][Full Text] [Related]
40. Coronary sinus plasma beta endorphin levels in cardioischemic patients undergoing PTCA.
Parlapiano C; Negri M; Tonnarini G; Borgia MC; Martuscelli E; Nigri A; Campana E; Giovanniello T; Pantone P
J Med; 1998; 29(5-6):339-42. PubMed ID: 10503168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
